Anzeige
Mehr »
Freitag, 16.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14UCN | ISIN: US30050B1017 | Ticker-Symbol: 9EH
Frankfurt
15.05.25 | 08:06
7,900 Euro
-4,82 % -0,400
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
EVOLENT HEALTH INC Chart 1 Jahr
5-Tage-Chart
EVOLENT HEALTH INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,8007,95015.05.
7,8008,00015.05.

Aktuelle News zur EVOLENT HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
EVOLENT HEALTH Aktie jetzt für 0€ handeln
SaExpert Outlook: Evolent Health Through The Eyes Of 9 Analysts2
08.05.Evolent Health Non-GAAP EPS of $0.06 misses by $0.04, revenue of $483.6M beats by $23.32M2
08.05.Evolent Health, Inc. - 8-K, Current Report1
08.05.Evolent Health, Inc.: Evolent Announces First Quarter 2025 Results399WASHINGTON, May 8, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for...
► Artikel lesen
28.04.Evolent Health stock target steady at $13 amid recontracting success4
22.04.Evolent Health, Inc. - 8-K, Current Report1
25.03.Here's What Challenged Evolent Health (EVH) Despite Strong Revenue Growth3
18.03.Evolent Health (EVH): Among Stocks Insiders Are Buying In March8
10.03.Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock1
24.02.Evolent Health stock target raised to $13 at Citizens JMP1
21.02.Piper Sandler cuts Evolent Health target to $16, maintains overweight3
21.02.Evolent Health outlines 15%-18% growth target for 2025 amid oncology trend challenges3
20.02.Evolent Health Non-GAAP EPS of -$0.02 misses by $0.03, revenue of $646.54M misses by $4.38M3
20.02.Evolent Health, Inc.: Evolent Announces Fourth Quarter and Full Year 2024 Results97Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1%...
► Artikel lesen
20.02.Evolent Health, Inc. - 8-K, Current Report1
12.02.Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)1
04.02.Evolent Health gains as activist Engaged Capital reaches cooperation agreement5
04.02.Evolent Health appoints new chair and independent director2
30.01.Evolent Health, Inc. - 8-K, Current Report1
14.01.What Analysts Are Saying About Evolent Health Stock5
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1